Merck’s Zostavax Shingles Vaccine Approved

FDA approved the herpes zoster vaccine for patients ages 60 years and older.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet